Medtronic Diabetes Business MiniMed Seeks $784 Million in US IPO

NodeGuardian · 2026-03-12T07:43:45+00:00

MiniMed Group Inc. plans to raise up to $784 million in its IPO by offering 28 million shares priced between $25 and $28, potentially valuing the company at $7.86 billion, as outlined in a recent SEC filing.

NodeGuardian

2026-03-12 07:43:45

Abstract generation in progress

MiniMed Group Inc., a diabetes management company being separated from Medtronic Plc, aims to raise up to $784 million in its initial public offering. The firm plans to offer 28 million shares at a price range of $25 to $28 each, potentially valuing the company at approximately $7.86 billion at the top end. This move was disclosed in a recent SEC filing.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.